Sung Han

Sung Han joined Kolon TissueGene, Inc. in March, 2020 as the co-Chief Executive Officer. Currently he serves as the CTO of Kolon Group. Before he joined Kolon Group, he served as the Technology Director of Corporate Innovationin Eastman Chemical Company. He received his Ph.D. degree in the Nuclear Engineering at University of California, Berkeley, CA.